References
- Can. J. Physiol. Pharmacol. v.72 The role of platelets in thrombosis and hemostasis Packham, M. A.
- Can. J. Physiol. Pharmacol. v.72 Platelets, vascular disease and diabetes mellitus Winocour, P. D.
- Blood Rev. v.9 Platelet activation Blockmans, D.;Deckmyn, H.;Vermylen, J.
- Biochim. Biophys. Acta v.1175 Intracellular calcium mobilization in rat platelets is adversely affected byt copper deficiency Johnson, W. T.;Dufault, S. N.
- Drugs and the delivery of oxygen to tissue Platelet activation and drugs that modify platelet function Meanwell, N. A.;Seiler, S. M.;Fleming, J.S.(Ed.)
- Pharmacol Rev. v.43 no.3 Pharmacological receptors on blood platelets Hourani, S. M. O.;Cusack, N. J.
- Am. J. Cardiol. Mechanism of platelet activation: thromboxane A₂as an amplifying signal for other agonists FitzGerald, G. A.
- Thromb. Res. v.37 Inhibition of human platelet aggregation by vitamin K Blackwell, G. J.;Radomski, M.;Moncada, S.
- Thromb. Res. v.57 Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones Ko, F. N.Sheu, S. J.;Lin, Y. M.;Huang, T. F.;Teng, C. M.
- Bioorg. Med. Chem. v.6 no.12 Synthesis and antiplatelet, antiinflammatory, and antiallergic activities of substituted-chloro-5,8-dimethoxy-1,4-naphthoquinone and related compounds Huang, L. J.;Chang, F. C.;Lee, K. H.;Wang, J. P.;Teng, C. M.;Kuo, S. C.
- Jpn. J. Pharmacol. v.76 no.2 Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets Liao, C. H.;Ko, F. N.;Kuo, S. C.;Teng, C. M.
- Biochem. Pharmacol. v.54 Thromboxane A₂synthase in-hibition and thromboxane A₂receptor blockade by 2-(4-cyanophenyl)amino-3-chloro-1,4-naphthalenedione(NQY-15) in rat platelets Chang, T. S.;Kim, H. M.;Lee, K. S.;Mar, W. C.;Ryu, C. K.;Moon, C. K.
- Arzneimittel-Forschung (Drug Res.) Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative Kang, W.S.;Joo, J. C.;Ryu, C. K.;Chung, K. H.;Ko, M. W.;Yuk, D. Y.;Yoo, H. S.;Yun, Y. P.
- J. Org. Chem. v.45 Reaction of 2.3-dichloro-1,4-naphthoquinone with arylamines in pyridine Argarwal, N. L.;Schaefer, W.
- J. Appl. Pharmacol. v.6 Effect of MCT(medium-chain triglyceride) and LCT(long-chain triglyceride) on myocardial ischemia/reperfusion injury and platelet aggregation in rat Lee, S. H.;Jung, Y. S.;Hong, J.;Kim, M. H.;Lee, H. J.;Baik, E. J.;Wang, H. J.;Kim, M. W.;Moon, C. H.
- J. Biol. Chem. v.269 Tight binding inhibitors of 85-Kda phospholipase A₂but not 14-KDa phospholipase A₂inhibit release of free arachidonate in thrombin-stimulated human platelets Bartoli, F.;Lin, H. K.;Ghomaschi, F.;Gelb, M. H.;Jain, M. K.;Apitz-Castro, R.
- Biochim. Biophys. Acta v.920 Evidence for the release of arachidonic acid through the selective action of phospholipase A₂in thrombin-stimulated human platelets Purdon, A. D.;Patelunas, D.;Smith, J. B.
- J. Clin. Invest. v.68 A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors Bennett, J. S.;Vilaire, G.;Burch, J. W.
- Adv. Cyclic. Nucleotide Res. v.9 Reciprocal regulation of human platelet cAMP levels by thromboxane A₂and protacyclin Gorman, R. R.;Fitzpatrick, F. A.;Miller, O. V.
- Thromb. Res. v.40 Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes coupling of receptors with high-affinity GTPase and adenylate cyclase Avdonin, P. V.;Svitina-Ulltina, I. V.;Leytin, V. L.;Tkachuk, V. A.
-
J. Biochem.
v.103
Elevation of cytosolic free
$Ca^{2+}$ is directly evoked by thromboxane A₂in human platelets during activation with collagen Moriyama, T.;Takamura, H.;Narita, H.;Tanaka, K.;Matsuura, T.;Kito, M. - Biochem. J. v.219 Thromboxaneinduced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changed in cytosolic free calcium Pollock, W. K.;Armstrong, R. A.;Brydon, L. J.;Jones, R. L.Maclntyre, D. E.
- The platelets : physiology and pharmacology The lumiaggregometer as a research and tool Feinman, R. D.;Detwiler, T. C.;Ingerman-Wo-jeuski, C.;Longenecker, GL.(Ed.)